KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Receivables (2018 - 2025)

Historic Receivables for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $54.8 million.

  • BioNTech SE's Receivables fell 5138.75% to $54.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.8 million, marking a year-over-year decrease of 5138.75%. This contributed to the annual value of $1.6 billion for FY2024, which is 3224.85% down from last year.
  • As of Q3 2025, BioNTech SE's Receivables stood at $54.8 million, which was down 5138.75% from $1.6 billion recorded in Q2 2025.
  • BioNTech SE's 5-year Receivables high stood at $14.2 billion for Q1 2022, and its period low was $23.1 million during Q1 2024.
  • Over the past 5 years, BioNTech SE's median Receivables value was $2.9 billion (recorded in 2021), while the average stood at $5.0 billion.
  • Per our database at Business Quant, BioNTech SE's Receivables soared by 707819.92% in 2021 and then crashed by 9966.61% in 2024.
  • Over the past 5 years, BioNTech SE's Receivables (Quarter) stood at $14.2 billion in 2021, then plummeted by 48.53% to $7.3 billion in 2022, then tumbled by 68.11% to $2.3 billion in 2023, then crashed by 32.25% to $1.6 billion in 2024, then crashed by 96.52% to $54.8 million in 2025.
  • Its last three reported values are $54.8 million in Q3 2025, $1.6 billion for Q2 2025, and $34.9 million during Q1 2025.